Table 2.

Control and follow-up values of drug initiation compared to baseline eGFR value.

Comparison pair		Base		Comparator
Base	Comparator	$\mathrm{\Delta }$ Control	$\mathrm{\Delta }$ Follow-up1	$\mathrm{\Delta }$ Control	$\mathrm{\Delta }$ Follow-up1
ARBs	ACEIs	3.31 (2.85, 3.37)	− 0.02 (− 0.25, 0.21)	3.11 (2.85, 3.37)	− 0.02 (− 0.25, 0.21)
Others	ACEIs	3.03 (2.91, 3.15)	0.38 (0.27, 0.49)	3.09 (2.69, 3.49)	0.14 (− 0.23, 0.51)
Others	ARBs	2.93 (2.81, 3.04)	0.37 (0.26, 0.47)	2.92 (2.45, 3.38)	− 0.42 (− 0.84, 0.01)

The baseline eGFR was measured within 1 year before the index date, and the follow-up₁ eGFR of each patient are the value measured in the first follow-up year. $\mathrm{\Delta }$ Control and $\mathrm{\Delta }$ Follow-up₁ are the difference of control (or the first-year follow-up) from the baseline. The values given in each cell are the mean and 95% confidence interval.